Management of Severe Body Pain in Sickle Cell Disease
Severe body pain in sickle cell disease (SCD) requires rapid triage, assessment, and aggressive parenteral analgesia with opioids as the mainstay of treatment, administered via scheduled around-the-clock dosing or patient-controlled analgesia. 1
Initial Pain Assessment and Management
Emergency/Hospital Setting
- Rapid triage and assessment are essential when home management fails to control pain
- First-line treatment: Parenteral opioids (e.g., morphine) 1
- Administer via patient-controlled analgesia (PCA) rather than continuous infusion
- Administration schedule: Scheduled around-the-clock dosing or patient-controlled analgesia 1
Supportive Measures
- Hydration: Maintain adequate hydration (but avoid excessive fluid administration) 1
- Oxygenation: Monitor oxygen saturation and provide supplemental oxygen to keep SpO2 above baseline or 96% (whichever is higher) 1
- Respiratory care: Use incentive spirometry to encourage deep inspiratory effort 1
- Temperature management: Maintain normothermia; avoid hypothermia which can lead to shivering, peripheral stasis, hypoxia and increased sickling 1
Multimodal Pain Management Approach
Pharmacological Interventions
Opioid analgesics:
Non-opioid analgesics:
- NSAIDs when not contraindicated
- Full doses of both mild opioid and nonsteroidal anti-inflammatory medications for home management 1
Regional anesthesia (when appropriate):
Non-pharmacological Interventions
- Heat application
- Rest
- Comfort measures
- Distraction techniques
- Early mobilization when appropriate
- Physiotherapy after moderate or major surgery 1
Transition to Oral Analgesia
- Implement an "oral tier approach" when transitioning from parenteral to oral analgesia:
- Scheduled oral opioid every 3 hours (patient may refuse doses)
- Additional oral opioids for breakthrough moderate pain (grade 4-7)
- Additional oral opioids for breakthrough severe pain (grade 8-10) 3
Monitoring and Complication Prevention
Close Monitoring For:
Acute chest syndrome: New infiltrate on chest radiograph with respiratory symptoms, chest pain, and/or hypoxemia 1
- Can develop after initial presentation for pain
- More common in patients with reactive airway disease
- Treat with oxygen, incentive spirometry, analgesics, antibiotics, and possibly transfusions
Respiratory status: Use continuous pulse oximetry until oxygen saturation is maintained at baseline in room air 1
Opioid side effects: Monitor for respiratory depression, nausea, constipation
Special Considerations
Addressing Stigma and Undertreatment
- Recognize that patients with SCD are often stigmatized when seeking pain relief
- Delays in addressing and undertreatment of SCD pain are common 1
- Patients and their caregivers typically know their disease best; incorporate shared decision-making 1
Perioperative Pain Management
- Pain team should be notified in advance if a patient with SCD is undergoing major surgery, particularly with history of opioid tolerance 1
- Use appropriate validated pain assessment scales and reassess regularly 1
- Encourage patients to report pain, particularly pain similar to their usual sickle pain 1
Common Pitfalls to Avoid
Undertreatment of pain: Studies document disparities in pain management between racial groups, with children of color receiving less pain medication 1
Excessive starvation: Patients with SCD have impaired urinary concentrating ability and become dehydrated easily. Clearly document and reinforce starvation instructions 1
Hypothermia: Avoid cooling as this leads to shivering, peripheral stasis, hypoxia and increased sickling 1
Delayed recognition of complications: Monitor closely for development of acute chest syndrome, which can develop after initial presentation for pain 1
Inadequate transition planning: Failure to plan for transition from parenteral to oral analgesia before discharge 3